Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Plague hazard assessment toolset


   Faculty of Engineering and Physical Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof C Molina-París, Prof G Lythe, Dr M Lopez-Garcia  Applications accepted all year round

About the Project

The pathogen of interest in this project is Yersinia pestis, a gram-negative bacterium and the causative agent of plague, a disease of humans and mammals which has been recognised since antiquity. Far from being obsolete, plague remains endemic in many parts of the world surviving in animal reservoirs.

The World Health Organisation estimates that approximately 800 cases are reported worldwide each year. Thus, plague remains a serious public health concern. Since it is highly pathogenic and can only be handled at the highest levels of biological containment, very few organisations are able to work with plague.

This PhD project aims to develop new within-host mathematical and computational models of Yersinia pestis infection acquired via the inhalation route and its treatment. In particular, the aim of this PhD project is to develop a plague hazard assessment mathematical and computational toolset, which can be used to compute the probability that an exposed individual will become infected as a function of dose of pathogen.

The mathematical and computational toolset will consist of two principal modules:
1) Human infection module: a within-host, mechanistic, stochastic model of the infection process of Yersinia pestis within humans will be developed. This module will predict the probability of infection and the time to symptoms for an individual exposed to a given dose of Yersinia pestis. Published data from animal models (primarily primate) will be leveraged, together with available human clinical case data.
2) Medical treatment module: a within-host mechanistic model of the effect of a range of treatments (e.g., different varieties of antibiotic) will be developed, allowing different dosing strategies to be tested.

Published pharmacokinetic data will be leveraged in model development.

Key questions to be addressed in this project are:

What is the probability that an exposed individual will become infected as a function of dose?

How many people within the exposed population may become casualties?

How many casualties will arise as a function of time? (This is essential to medical planning, e.g. quantity of MedCM to be stockpiled, number of hospital beds required).

How effective must a given MedCM treatment be to reduce casualties by x%?

How soon must a given MedCM treatment be administered, in order to reduce casualties by x%?

Funding Notes

UK/EU – Engineering & Physical Sciences Research Council Studentships paying academic fees of £4,500 for Session 2019/20, together with a maintenance grant of £15,009 paid at standard Research Council rates for 4 years. UK applicants will be eligible for a full award paying tuition fees and maintenance.
European Union applicants will be eligible for an award paying tuition fees only, except in exceptional circumstances, or where residency has been established for more than 3 years prior to the start of the course.

Where will I study?